Please provide your email address to receive an email when new articles are posted on . Interstitial lung disease and pulmonary arterial hypertension associated with scleroderma often require ...

Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Iliad SA (EPA:ILD) with a market-capitalization of €5.5b, rarely draw their attention. Surprisingly ...

Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider Jeffrey J. Swigris, ...

Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as Iliad SA (EPA:ILD), with a market cap of €5.8b, often get neglected by retail investors.

Interstitial Lung Disease (ILD) is a chronic condition marked by lung inflammation and scarring that makes breathing difficult. Early diagnosis is vital for effective management. Contributing factors ...

More clinical guidance is needed for monitoring interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA), according to a new commentary. Though ILD is a leading cause of death among ...

Serac Healthcare, a clinical radiopharmaceutical company, and the University of Exeter have announced the commencement of a Phase II study involving a novel molecular SPECT imaging agent, ...